• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

9.200 -0.290 (-3.06%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CNS Pharmaceuticals, Inc. - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
21 22 Next >
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Adds Italy to Growing Portfolio of Countries for Berubicin Study
April 06, 2023
Via Investor Brand Network
Why CNS Pharmaceuticals Shares Are Trading Higher
April 06, 2023
CNS Pharmaceuticals Inc (NASDAQ: CNSP) shares are trading higher by 15.47% to $1.00 after the company announced it received approval from the Competent Authority and the central Ethics Committee in... 
Via Benzinga
CNS Pharmaceuticals Receives Approval from Competent Authority and Central Ethics Committee in Italy for Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
April 06, 2023
Via ACCESSWIRE
Broad Cancer Analysis Finds Possibility for Tumor Reduction in Nearly All Cancers
April 05, 2023
Via Investor Brand Network
CNS Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
April 03, 2023
Via ACCESSWIRE
Study Finds Repeated Head Trauma Increases Brain Cancer Risk
March 07, 2023
Via Investor Brand Network
Researchers Find That Nutraceuticals May Be Useful in Preventing and Treating Cancer
January 23, 2023
Via Investor Brand Network
Topics Death
Stocks That Hit 52-Week Lows On Monday
April 03, 2023
  On Monday, 76 companies set new 52-week lows. 
Via Benzinga
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces FY 2022 Results, Corporate Update
April 03, 2023
Via Investor Brand Network
AI Screens Brain Tumor Genes in Less Than Two Minutes
March 30, 2023
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation in Upcoming Virtual Investor Event
March 29, 2023
Via Investor Brand Network
Lighting Up Malignant Tissues Could Boost Precision of Surgical Removal
March 24, 2023
Via Investor Brand Network
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Hits Key Milestone in Global GBM Clinical Trial with the Enrollment of First Patient in Spain
March 24, 2023
Via Investor Brand Network
Normalizing Blood Vessels in Tumors Could Improve Brain Cancer Immunotherapy
March 20, 2023
Via Investor Brand Network
Research Suggests Brain Cancers Could Be Detected Via Blood Tests
March 14, 2023
Via Investor Brand Network
Topics Death
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces It Has No Exposure to Silicon Valley Bank Issues
March 13, 2023
Via Investor Brand Network
Study Documents Dangers of Halting Opioid Treatments for Chronic Pain
March 09, 2023
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls First Patient in Switzerland in Potentially Pivotal Berubicin Trial
March 09, 2023
Via Investor Brand Network
Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 28, 2023
Gainers Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) shares jumped 153% to $3.24 after the company announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early... 
Via Benzinga
Researchers Find Ways to Ease Cancer Treatment Outcome Prediction
February 23, 2023
Via Investor Brand Network
New AI Tool Helps Personalize Breast Cancer Therapy
February 17, 2023
Via Investor Brand Network
Topics Artificial Intelligence
Stocks That Hit 52-Week Lows On Wednesday
February 15, 2023
  On Wednesday, 35 stocks hit new 52-week lows. 
Via Benzinga
Research Finds Most Pediatric Oncologists Don’t Discuss Prognosis with Caregivers
February 14, 2023
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls First Patient in Spain in Key Global Trial Studying Berubicin for Treatment of GBM
February 07, 2023
Via Investor Brand Network
Study Finds Boosting White Blood Cell Counts May Improve Treatment Outcomes
February 06, 2023
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Pleased with Early Results from Global Clinical Trial
February 03, 2023
Via Investor Brand Network
Study Determines That How Proteins Move May Influence Brain Tumor Growth
January 30, 2023
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses ‘Lifeblood’ of Phase 2 Berubicin Trial
January 24, 2023
Via Investor Brand Network
Researchers Design a New Way to Kill Cancer Using Cancer Cells
January 13, 2023
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin to Be Evaluated in Investigator-Initiated Phase 1b/2 Trial
January 12, 2023
Via Investor Brand Network
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
21 22 Next >
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap